VOYAGER THERAPEUTICS INC (VYGR:NASDAQ)
$4.13 0.17 (4.2929%)
Analysed VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) News Sources
Voyager Therapeutics Conference: CEO Calls 2026 “Year of Tau,” Eyes BBB Capsid Clinic Debut
23-03-2026
marketbeat.com
Does Voyager Therapeutics’ (VYGR) Widening Annual Loss Redefine the Risk-Reward in Its Neurology Pipeline?
12-03-2026
yahoo.com
Voyager Therapeutics (VYGR) Reports Q4 Loss, Beats Revenue Estimates
09-03-2026
yahoo.com
Voyager Therapeutics: Q4 Earnings Snapshot
09-03-2026
yahoo.com
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
09-03-2026
yahoo.com
Voyager Therapeutics Touts Tau, Gene Therapy and NeuroShuttle Roadmap, Sees Cash Runway Into 2028
02-03-2026
marketbeat.com
Fortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Lag Estimates
26-02-2026
yahoo.com
Voyager to Present at Upcoming Investor Conferences
09-02-2026
yahoo.com
Gene Therapy Market Outlook 2026-2031, Featuring Profiles of REGENXBIO, Oxford Biomedica, Voyager Therapeutics and More
23-01-2026
yahoo.com
Voyager Therapeutics (VYGR): Strong Q3 Prompts Bullish Coverage
10-12-2025
yahoo.com
What is the current price of VOYAGER THERAPEUTICS INC (VYGR:NASDAQ)?
The current price of VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) is $4.13.
VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) absolute price change since previous trading day?
The absolute price change of VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) since the previous trading day is $0.17.
VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) percentage price change since previous trading day?
The percentage price change of VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) since the previous trading day is 4.2929%.
What is the most recent average sentiment score for VOYAGER THERAPEUTICS INC (VYGR:NASDAQ)?
The most recent average sentiment score for VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for VOYAGER THERAPEUTICS INC (VYGR:NASDAQ)?
The most recent sentiment for VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) is .
SEC-8K** Filing Available For VOYAGER THERAPEUTICS INC (VYGR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.